Vimarsana
Biggest News Aggregation in the World

Robert Flamm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Flamm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Flamm Today - Breaking & Trending Today

ProKidney Appoints Bruce Culleton, MD, as Executive Vice - Vimarsana News

ProKidney Appoints Bruce Culleton, MD, as Executive Vice

- Brings more than 20 years of academic and industry experience with extensive expertise in kidney disease - WINSTON-SALEM, N.C., July 17, 2023 (GLOBE...

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and ... - Vimarsana News

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and ...

- Brings more than 20 years of academic and industry experience with extensive expertise in kidney disease -

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference - Vimarsana News

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

WINSTON-SALEM, N.C., June 01, 2023 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , today announced that Dr. Tim Bertram, Chief... | June 1, 2023

VTv Therapeutics : Announces 2023 First Quarter Financial Results and Provides Corporate Update - Form 8-K - Vimarsana News

VTv Therapeutics : Announces 2023 First Quarter Financial Results and Provides Corporate Update - Form 8-K

VTv Therapeutics Announces 2023 First Quarter Financial Results and Provides Corporate Update HIGH POINT, N.C. - May 11, 2023 - vTv Therapeutics Inc. , a... | May 11, 2023

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights - Vimarsana News

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

WINSTON-SALEM, N.C., March 28, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney